Literature DB >> 21327426

High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis.

Danieli Castro Oliveira de Andrade1, Sonia Cristina de Magalhães Souza, Jozélio Freire de Carvalho, Liliam Takayama, Claudia Teresa Lobato Borges, José Mendes Aldrighi, Rosa Maria Rodrigues Pereira.   

Abstract

Bone mass was only previously studied in juvenile dermatomyositis/polymyositis (DM/PM) patients. Therefore, the objective this study was to evaluate the prevalence of osteoporosis and fractures in adult DM/PM. Forty female DM/PM and 78 age-, gender-, and BMI-matched healthy controls were studied. Medical charts and clinical interviews of all patients were evaluated for demographic and clinical data, including disease activity, cumulative doses of glucocorticoid, menarche and menopause age, and fractures. Bone mineral density (BMD) using dual X-ray absorptiometry (DXA) were measured at lumbar spine (L1-L4) and hip. A decreased BMD in lumbar spine [0.902 (0.136) vs. 0.965 (0.141) g/cm(2), P = 0.022] and femoral neck [0.729 (0.12) vs. 0.784 (0.127) g/cm(2), P = 0.027] was observed in patients compared to controls. In addition, osteoporosis was more frequent in patients than in controls in both lumbar spine (20 vs. 3.8%, P = 0.007) and the femoral neck (27.5 vs. 10.3%, P = 0.016). Moreover, a high prevalence of fractures was found in patients in comparison to healthy subjects (17.9 vs. 5.1%, P = 0.040; OR = 3.92; CI 95%:1.07-14.33). Comparing DM/PM patients with (n = 17) and without (n = 23) osteoporosis/fractures, significant differences were observed regarding age [56.8 (11.9) vs. 48.3 (13.2) years, P = 0.042], weight [62.05 (13.56) vs. 71.51 (11.46) kg, P = 0.022] and frequency of post menopausal women (94.1 vs. 65.2%, P = 0.0002). No differences were observed concerning height, lean mass, total fat mass, disease activity, mean value of creatine kinase, cumulative glucocorticoid dose, or bisphosphonate use. Logistic regression analysis revealed a negative association between the presence of osteoporosis/fractures and weight (OR: 0.92, 95% CI: 0.85-0.98; P = 0.016). This is the first study that analyzed bone mass in adult DM/PM patients and it demonstrated that about one quarter of these patients have osteoporosis/fracture.

Entities:  

Mesh:

Year:  2011        PMID: 21327426     DOI: 10.1007/s00296-011-1821-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  FRAX and its applications to clinical practice.

Authors:  John A Kanis; Anders Oden; Helena Johansson; Fredrik Borgström; Oskar Ström; Eugene McCloskey
Journal:  Bone       Date:  2009-02-03       Impact factor: 4.398

3.  Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment.

Authors:  Abdellah El Maghraoui; Asmaa Rezqi; Aziza Mounach; Lahsen Achemlal; Ahmed Bezza; Imad Ghozlani
Journal:  Rheumatology (Oxford)       Date:  2010-03-31       Impact factor: 7.580

4.  Systemic sclerosis and bone loss: the role of the disease and body composition.

Authors:  R B C Souza; C T L Borges; L Takayama; J M Aldrighi; R M R Pereira
Journal:  Scand J Rheumatol       Date:  2006 Sep-Oct       Impact factor: 3.641

5.  Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise.

Authors:  Khayriah A Alsufyani; Olivia Ortiz-Alvarez; David A Cabral; Lori B Tucker; Ross E Petty; Helen Nadel; Peter N Malleson
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

6.  [Severe osteoporosis with vertebral crushes in juvenile dermatomyositis. Effect of oral alendronate therapy].

Authors:  Cristina Tau; Ricardo Russo
Journal:  Medicina (B Aires)       Date:  2007       Impact factor: 0.653

7.  Bone mineral density of Brazilian girls with juvenile dermatomyositis.

Authors:  T C M de Castro; M T R A Terreri; V L Szejnfeld; C Len; A S M da Fonseca; M O E Hilário
Journal:  Braz J Med Biol Res       Date:  2005-02-15       Impact factor: 2.590

8.  Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis.

Authors:  A Ponyi; G Borgulya; T Constantin; A Váncsa; L Gergely; K Dankó
Journal:  Rheumatology (Oxford)       Date:  2004-09-20       Impact factor: 7.580

Review 9.  Individualizing fracture risk prediction.

Authors:  Tineke A C M van Geel; Joop P W van den Bergh; Geert-Jan Dinant; Piet P Geusens
Journal:  Maturitas       Date:  2010-01-06       Impact factor: 4.342

10.  Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.

Authors:  C Book; M Karlsson; K Akesson; L Jacobsson
Journal:  Scand J Rheumatol       Date:  2008 Jul-Aug       Impact factor: 3.641

View more
  7 in total

1.  Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score.

Authors:  Cynthia Wei-Sheng Lee; Chih-Hsin Muo; Ji-An Liang; Fung-Chang Sung; Chung-Y Hsu; Chia-Hung Kao
Journal:  Endocrine       Date:  2015-10-01       Impact factor: 3.633

Review 2.  Menopause and Rheumatic Disease.

Authors:  Mitali Talsania; Robert Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2017-05       Impact factor: 2.670

Review 3.  The role of IL-1β in the bone loss during rheumatic diseases.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Carubbi; Vasiliki Liakouli; Francesca Zazzeroni; Paola Di Benedetto; Onorina Berardicurti; Edoardo Alesse; Roberto Giacomelli
Journal:  Mediators Inflamm       Date:  2015-04-12       Impact factor: 4.711

4.  Risk factors for osteoporosis, falls and fractures in hereditary myopathies and sporadic inclusion body myositis - A cross sectional survey.

Authors:  F Danckworth; N Karabul; A Posa; F Hanisch
Journal:  Mol Genet Metab Rep       Date:  2014-02-11

5.  The risk of fracture and prevalence of osteoporosis is elevated in patients with idiopathic inflammatory myopathies: cross-sectional study from a single Hungarian center.

Authors:  Anett Vincze; Levente Bodoki; Katalin Szabó; Melinda Nagy-Vincze; Orsolya Szalmás; József Varga; Katalin Dankó; János Gaál; Zoltán Griger
Journal:  BMC Musculoskelet Disord       Date:  2020-07-02       Impact factor: 2.362

6.  Myostatin and markers of bone metabolism in dermatomyositis.

Authors:  Katharina Kerschan-Schindl; Wolfgang Gruther; Ursula Föger-Samwald; Christine Bangert; Stefan Kudlacek; Peter Pietschmann
Journal:  BMC Musculoskelet Disord       Date:  2021-02-05       Impact factor: 2.362

Review 7.  Bone Health in Idiopathic Inflammatory Myopathies: Diagnosis and Management.

Authors:  Anett Vincze; János Gaál; Zoltán Griger
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.